Eukaryotic protein processing: Endoproteolysis of precursor proteins

Current Opinion in Biotechnology

Volumn 8, Issue 5, 1997, Pages 602-607

  Seidah, Nabil G ^a   Chrétien, Michel ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR; CELL ADHESION MOLECULE; ENZYME; ENZYME PRECURSOR; GROWTH FACTOR; NEUROPEPTIDE; PEPTIDE HORMONE; PROTEIN PRECURSOR; PROTEINASE; RECEPTOR PROTEIN; SUBTILISIN; VIRUS GLYCOPROTEIN;

AMINO ACID SEQUENCE; BIOTECHNOLOGY; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL METABOLISM; CELL TYPE; CELLULAR DISTRIBUTION; EUKARYOTE; HUMAN; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN LOCALIZATION; PROTEIN PROCESSING; SHORT SURVEY;

EUKARYOTA; MAMMALIA;

EID: 0343307146     PISSN: 09581669     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0958-1669(97)80036-5     Document Type: Article

References (45)

1. Neurath H: Proteolytic processing and physiological regulation. Trends Biochem Sci 1989, 14:268-271.
2. Chrétien M, Li CH: Isolation, purification and characterization of lipotropic hormone from sheep pituitary glands. Can J Biochem 1967, 45:1163-1174.
3. Steiner DF, Cunningham D, Spiegelman L, Aten B: Insulin biosynthesis: evidence for a precursor. Science 1967, 157:697-699.
4. Seidah NG, Chrétien M: Proprotein and pro-hormone convertases of the subtilisin family. Recent developments and future perspectives. Trends Endocrinol Metab 1992, 3:133-140.
5. Van de Ven WJM, Roebroek AJM: Structure and function of eukaryotic proprotein processing enzymes of the subtilisin family of serine proteases. Crit Rev Oncog 1993, 4:115-136.
6. Seidah NG, Chrétien M, Day R: The family of subtilisin/kexin like proprotein and pro-hormone convertases: divergent or shared functions. Biochimie 1994, 76:197-209.
7. Rehemtulla A, Kaufman RJ: Protein processing within the secretory pathway. Curr Opin Biotechnol 1992, 3:560-565.
8. Rouillé Y, Duguay SJ, Lund K, Furuta M, Gong QM, Lipkind G, Oliva AA, Chan SJ, Steiner DF: Proteolytic processing mechanisms in the biosynthesis of neuroendocrine peptides - the subtilisin-like proprotein convertases. Front Neuroendocrinol 1995, 16:322-361.
9. Seidah NG, Hamelin J, Mamarbachi M, Dong W, Tadros H, Mbikay M, Chrétien M, Day R: cDNA structure, tissue distribution and chromosomal localization of rat PC7: a novel mammalian proprotein convertase closest to yeast kexin-like proteinases. Proc Natl Acad Sci USA 1996, 93:342-355. This paper describes cloning of the cDNA sequence of PC7 and analysis of its tissue expression. This report also revealed that both PC7 and furin exhibit a widespread tissue distribution.
10. Seidah NG, Day R, Marcinkiewicz M, Chrétien M: Precursor convertases: an evolutionary ancient, cell-specific, combinatorial mechanism yielding diverse bioactive peptides and proteins. Ann NY Acad Sci USA 1997, in press.
11. Martens GJ, Braks JA, Eib DW, Zhou Y, Lindberg I: The neuroendocrine polypeptide 7B2 is an endogenous inhibitor of prohormone convertase PC2. Proc Natl Acad Sci USA 1994, 91:5784-5787.
12. Benjannet S, Savaria D, Chrétien M, Seidah NG: 7B2 is a specific intracellular binding protein of the pro-hormone convertase PC2. J Neurochem 1995, 64:2303-2311.
13. 2-terminal sequence of a novel porcine anterior pituitary polypeptide: homology to proinsulin, secretin and Rous sarcoma virus transforming protein TVFV60. FEBS Lett 1982, 147:261-266.
14. Lusson J, Benjannet S, Hamelin J, Savaria D, Lazure C, Chrétien M, Seidah NG: Implication of the RRGD sequence of the proprotein convertase PC1 in zymogen processing and cellular trafficking. Biochem J 1997, 326:737-744. This is the first indication ever that the RGD motif in convertases has functional significance in terms of stability and intracellular routing of PC1.
15. Gluschankof P, Fuller R: A C-terminal domain conserved in precursor processing proteases is required for intramolecular N-terminal maturation of pro-Kex2 protease. EMBO J 1994, 13:2280-2288.
16. Zhong M, Benjannet S, Lazure C, Munzer S, Seidah NG: Functional analysis of human PACE4-A and PACE4-C isoforms: identification of a new PACE4-CS isoform. FEBS Lett 1996, 396:31-36.
17. De Bie I, Marcinkiewicz M, Malide D, Lazure C, Nakayama K, Bendayan M, Seidah NG: The isoforms of the proprotein convertase 5 are sorted to different subcellular compartments. J Cell Biol 1996, 135:1261-1275. This is the first known case where from a single gene, via alternative splicing of the derived heteronuclear RNA, one can generate two isoforms which are sorted to different subcellular compartments. Furthermore, in the case of PC5, within the cell, the two isoforms PC5-A and PC5-B should process different precursor proteins.
18. Shinde U, Inouye M: Intramolecular chaperones and protein folding. Trends Biochem Sci 1993, 18:442-446.
19. Benjannet S, Rondeau N, Paquet L, Boudreault A, Lazure C, Chrétien M, Seidah NG: Comparative biosynthesis, post-translational modifications and efficiency of prosegment cleavage of the pro-hormone convertases PC1 and PC2: glycosylation, sulfation and identification of the intracellular site of prosegment cleavage of PC1 and PC2. Biochem J 1993, 294:735-743.
20. Anderson ED, VanSlyke JK, Thulin GD, Jean F, Thomas G: Activation of the furin endoprotease is a multi-step process: requirements for acidification and internal propeptide cleavage. EMBO J 1997, 16:1508-1518. This is the first report which shows that for one member of the proprotein convertase family the pro-segment acts as an inhibitor of the enzyme until it is disposed of in the acidic environment of the trans Golgi network. This report provides an elegant demonstration of some of the functions of the pro-segment in proprotein convertases, taking furin as an example. It is considered outstanding since the pro-segment is a good model polypeptide from which one can, through modelling, derive specific peptide inhibitors of the proprotein convertases.
21. Munzer JS, Basak A, Zhong M, Mamarbachi M, Hamelin J, Savaria D, Lazure C, Benjannet S, Chrétien M, Seidah NG: In Vitro characterization of the novel proprotein convertase PC7. J Biol Chem 1997, 272:19672-19681. The first report on the in vitro properties of recombinant PC7 which provided evidence for a carboxy-terminally extended P domain as compared to kexin and furin.
22. Shapiro J, Sciaky N, Lee J, Bosshart H, Angeletti RH, Bonifacino JS: Localization of endogenous furin in cultured cell lines. J Histochem Cytochem 1997, 45:3-12.
23. Seidah NG, Day R, Hamelin J, Gaspar A, Collard MW, Chrétien M: Testicular expression of PC4 in the rat-molecular diversity of a novel germ cell-specific Kex2/subtilisin-like proprotein convertase. Mol Endocrinol 1992, 6:1559-1570.
24. Mbikay M, Tadros H, Lerner CP, Chen A, El-Alfy M, Clermont Y, Seidah NG, Chrétien M, Simpson EM: Impaired fertility in mice deficient for the testicular germ-cell protease PC4. Proc Natl Acad Sci USA 1997, 94:6842-6846. The first report on the production of a proprotein convertase-null mouse. The impaired male fertility phenotype suggested a certain degree of functional redundancy of proprotein convertase functions.
25. Malide D, Seidah NG, Chrétien M, Bendayan M: Electron microscopic immunocytochemical evidence for the involvement of the convertases PC1 and PC2 in the processing of proinsulin in pancreatic β-cells. J Histochem Cytochem 1995, 43:11-19.
26. Jackson RS, Creemers JWM, Ohagi S, Raffin-Sanson ML, Sanders L, Montague C, Hutton JC, O'Rahilly S: Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 (PC1) gene. Nat Genet 1997, 16:303-306. This is the first report of a human pathology associated with the silencing of one member of the proprotein convertase family, namely PC1. Furthermore, this report demonstrates that a certain redundancy must exit in the function of some proprotein convertases, since the absence of PC1 expression does not lead to a lethal phenotype.
27. Zheng M, Seidah NG, Pintar JE: The developmental expression in the rat CNS and peripheral tissues of proteases PC5 and PACE4 mRNAs: comparison with other proprotein processing enzymes. Dev Biol 1997, 181:268-283.
28. Mains RE, Berard CA, Denault JB, Zhou A, Johnson RC, Leduc R: PACE4-a subtilisin-like endoprotease with unique properties. Biochem J 1997, 321:587-593.
29. Jean F, Basak A, DiMaio J, Seidah NG, Lazure C: An internally quenched fluorogenic substrate of prohormone convertase 1 and furin leads to a potent prohormone convertase inhibitor. Biochem J 1995, 307:689-695.
30. Jean F, Boudreault A, Basak A, Seidah NG, Lazure C: Fluorescent peptidyl substrates as an aid in studying the substrate specificity of human prohormone convertase PC1 and human furin and designing a potent irreversible inhibitor. J Biol Chem 1995, 270:19225-19231.
31. Matthews DJ, Goodman LJ, Gorman CM, Wells JA: A survey of furin substrate specificity using substrate phage display. Protein Sci 1994, 3:1197-1205.
32. Nachtigal MW, Ingraham HA: Bio-activation of MIS during gonadal development by a kex2/subtilisin-like endoprotease. Proc Natl Acad Sci USA 1996, 93:7711-7716. This is the first demonstration of the importance of PC5 in sexual differentiation, via the activation of pro-Müllerian inhibiting substance. This report led the authors to pursue their efforts towards the derivation of PC5-null mice.
33. Campan M, Yoshizumi M, Seidah NG, Lee ME, Bianchi C, Haber E: Increased proteolytic processing of protein tyrosine phosphatase mu in confluent vascular endothelial cells. The role of PCS, a member of the subtilisin-family. Biochemistry 1996, 35:3797-3802.
34. Jean F, Basak A, Rondeau N, Benjannet S, Hendy GN, Seidah NG, Chrétien M, Lazure C: Enzymic characterization of murine and human prohormone convertase-1 (mPC1 and hPC1) expressed in mammalian GH4C1 cells. Biochem J 1993, 292:891-900.
35. Bravo DA, Gleason JB, Sanchez RI, Roth RA, Fuller RS: Accurate and efficient cleavage of the human insulin proreceptor by the human proprotein-processing protease furin. Characterization and kinetic parameters using the purified, secreted soluble protease expressed by a recombinant baculovirus. J Biol Chem 1994, 269:25830-25837.
36. Schlokat U, Fischer BE, Herlitschka S, Antoine G, Preininger A, Mohr G, Himmelspach M, Kistner O, Falkner FG, Dorner F: Production of highly homogeneous and structurally intact recombinant von Willebrand factor multimers by furin-mediated propeptide removal in vitro. Biotechnol Appl Biochem 1996, 24:257-267. In the biotechnology field, a number of growth factors, neurotrophins, coagulation factors etc., are produced in large scale for pharmacological purposes. This is the first report which details the advantages of large scale processing of a secreted unprocessed precursor in vivo with furin.
37. Ayoubi TAY, Meulemans SMP, Roebroek AJM, Van de Ven WJM: Production of recombinant proteins in chinese hamster ovary cells overexpressing the subtilisin-like proprotein converting enzyme furin. Mol Biol Rep 1996, 23:87-95. This is the first report to deal with the advantage of cellular overexpression of both a convertase and its substrate in order to produce large quantities of bioactive von Willebrand factor ex vivo.
38. Nakayama K: Purification of recombinant soluble forms of furin produced in chinese hamster ovary cells. Methods Enzymol 1994, 244:167-175.
39. Yi Z, Lindberg I: Purification and characterization of the prohormone convertase PC1(PC3). J Biol Chem 1993, 268:5615-5623.
40. Lamango NS, Zhu X, Lindberg I: Purification and enzymatic characterization of recombinant prohormone convertase 2: stabilization of activity by 21 kDa 7B2. Arch Biochem Biophys 1996, 330:238-250. This is a critical report which demonstrates the presence of the pan-neuronal protein 7B2 is necessary to obtain large quantities of bioactive PC2 secreted in the medium of PC2-overexpressing cells.
41. Velander WH, Lubon H, Drohan WN: Transgenic livestock as drug factories. Sci Am 1997, 276:70-74. Review outlining the advantages of overproduction of proteins and their cognate convertases in the mammary gland of livestock animals.
42. Wasley LC, Rehemtulla A, Bristol JA, Kaufman RJ: PACE/furin can process the vitamin-K-dependent pro-factor-IX precursor within the secretory pathway. J Biol Chem 1993, 268:8458-8465.
43. Subramanian A, Paleyanda RK, Lubon H, Williams BL, Gwazdauskas FC, Knight JW, Drohan WN, Velander WH: Rate limitations in post-translational processing by the mammary gland of transgenic animals. Ann NY Acad Sci 1996, 782:87-96.
44. Ghosh S, Lowenstein JM: A multifunctional vector system for heterologous expression of proteins in Escherichia coli-expression of native and hexahistidyl fusion proteins, rapid purification of the fusion proteins, and removal of the fusion peptide by Kex2 protease. Gene 1996, 176:249-255. The exploitation of the fine specificity of convertases in the large scale bacterial production of desired proteins through the specific cleavage of derivative fusion proteins is exemplified in this report. Although a yeast kexin enzyme was used, the principle is applicable to the other mammalian proprotein convertases.
45. Chrétien M, Mbikay M, Gaspar L, Seidah NG: Proprotein convertases and the pathophysiology of human diseases: prospective considerations. Proc Ass Am Phys 1995, 107:47-66.